Corebridge Financial’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-49,045
| Closed | -$38.8K | – | 950 |
|
|
2025
Q1 | $38.8K | Sell |
49,045
-727
| -1% | -$574 | ﹤0.01% | 2792 |
|
|
2024
Q4 | $82.1K | Sell |
49,772
-3,757
| -7% | -$6.2K | ﹤0.01% | 2641 |
|
|
2024
Q3 | $187K | Sell |
53,529
-330
| -0.6% | -$1.16K | ﹤0.01% | 2259 |
|
|
2024
Q2 | $177K | Buy |
+53,859
| New | +$177K | ﹤0.01% | 2267 |
|